COVID-19 진단제를 포함한 세계 생명과학 툴 및 시약 시장 규모는 2023년 594억 달러, 2024년 532억 달러에서 예측 기간 동안 연평균 4.6% 성장하여 2029년 말에는 665억 달러에 달할 것으로 예상됩니다.
생명과학 툴 및 시약 부문은 2024년 513억 달러에서 연평균 5.3% 성장하여 2029년 664억 달러에 달할 것으로 예상됩니다. 또한, COVID-19 진단 검사 부문은 2024년 19억 달러에서 2029년 1억 730만 달러로 감소하여 2024-2029년 예측 기간 동안 마이너스 43.5%의 CAGR을 기록할 것으로 예상됩니다.
세계 생명과학 툴 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
개요
생명과학의 제품 개발
PESTLE 분석
Porter's Five Forces 분석
제3장 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 과제
시장 기회
제4장 신기술과 개발
AI와 머신러닝
IoT
데이터 수집 자동화
기기 추적
원격 분석
상호접속성
예측 보수
생명과학 실험실의 로봇
3D/4D 세포배양
유해 화학제품 사용 절감
제5장 시장 세분화 분석
부문별 내역
시장 분석 : 유형별
COVID-19 진단 검사 시장
생명과학 툴 및 시약 시장
시장 내역 : 용도별
유전체학
단백질체학
세포생물학
줄기세포
이미징 툴과 기술
동물 모델
후생유전학 툴과 시약
생명과학 툴 및 시약
기타
지역적 내역
시장 내역 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
주요 기업 분석
PCR 기술과 시약
마이크로플레이트 리더/ELISA 장비
항체
ELISA 검사
생명과학 키트와 어세이
COVID-19 진단
전략 분석
제품 소개
협업과 계약
M&A
기타 전략적 전개
제7장 생명과학 툴 및 시약 시장의 지속가능성 : ESG 관점
ESG : 소개
환경
사회 문제
지배구조
생명과학 툴 및 시약 업계의 ESG 퍼포먼스 분석
패키징
ESG 리스크 평가
ESG 관련 기회와 리스크
BCC의 결론
제8장 부록
조사 방법
약어
정보 출처
기업 개요
BD
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MERCK KGAA
PROMEGA CORP.
QIAGEN
REVVITY
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
ksm
영문 목차
영문목차
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
The global market for life science tools and reagents is expected to grow from $51.3 billion in 2024 to reach $66.4 billion by 2029, at a CAGR of 5.3% during the forecast period of 2024-2029.
The global market for COVID-19 diagnostics tests is expected to decline from $1.9 billion in 2024 to reach $107.3 million by 2029, at a negative CAGR of 43.5% during the forecast period of 2024-2029.
Report Scope
This report provides an analysis of the market for life sciences tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape and market dynamics such as drivers, restraints and opportunities. It sizes of the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science instruments include hybridization systems, PCR, Western blotting instruments, and ELISA instruments. The regions whose markets are analyzed are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Markets are also analyzed by application.
Report Includes
85 data tables and 44 additional tables
An analysis of the global markets for life science tools and reagents, including COVID-19 diagnostics products
Analyses of the global market trends, with market revenue data (sales figures) from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
An estimate of the market size and revenue forecast for the market for life science tools and diagnostics, and a corresponding market share analysis based on product type, application and region
Highlights of the current and future market potential of life science tools and diagnostics, along with an analysis of the competitive landscape, regulatory scenario and technological advances
Facts and figures pertaining to the market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables
An assessment of current products and identification of new potential markets for novel products and assay development
A discussion on how scientific trends, government policies and the economy in general affect this market, as well as how the life science tools and diagnostics industry differs from the pharmaceutical and drug discovery industry
A discussion of sustainability trends in the market, with emphasis on consumer attitudes, an analysis of companies' ESG scores, the future of ESG, case studies, and the ESG practices of leading companies
An analysis of the key patent grants and recently published patents
Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activity and the outlook for venture funding
Profiles of the leading market players, including Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Roche and Qiagen
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Product Development in Life Science
PESTLE Analysis
Political
Economic
Social
Technological
Environmental
Legal
Environmental
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competition in the Industry
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Increasing Investments in R&D
Diagnostic Pathways
Prevalence of Chronic Diseases
Broadening Range of Applications
Market Restraints
End of COVID-19 pandemic
Cybersecurity
Lack of Reproducibility of Antibodies
Market Challenges
End Users and Regulatory Compliance
Market Opportunities
Infectious Diseases on the Rise
New Technologies
Chapter 4 Emerging Technologies and Developments
AI and Machine Learning
Internet of Things (IoT)
Automation of Data Collection
Tracking of Equipment
Remote Analysis
Interconnectivity
Predictive Maintenance
Robots in Life Science Labs
3D/4D Cell Culturing
Reduced Use of Harmful Chemicals
Chapter 5 Market Segmentation Analysis
Segmental Breakdown
Market Analysis by Type
COVID-19 Diagnostic Tests Market
Market for Life Science Tools and Reagents
Market Breakdown by Application
Genomics
Proteomics
Cell Biology
Stem Cells
Imaging Tools and Techniques
Animal Models
Epigenetics Tools and Reagents
Metabolomics
Other Applications
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Analysis of Leading Companies
PCR Technologies and Reagents
Microplate Readers/ELISA Instruments
Antibodies
ELISA Tests
Life Science Kits and Assays
COVID-19 Diagnostics
Strategic Analysis
Product Introductions
Collaborations and Agreements
Mergers and Acquisitions
Other Strategic Developments
Chapter 7 Sustainability in the Life Sciences Tools and Reagents Market: An ESG Perspective
Introduction to ESG
Environment
Social Issues
Governance
ESG Performance Analysis in the Life Science Tools and Reagents Industry
